06:08 EDT Akero Therapeutics (AKRO) jumps 18% to $54.74 after Novo Nordisk (NVO) buyout offer
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKRO:
- Akero Therapeutics to be acquired by Novo Nordisk for up to $5.2B in cash
- Akero Therapeutics Settles Loan with Hercules Capital
- Strategic Value and Market Positioning Drive Buy Rating for Akero Therapeutics
- Akero Therapeutics assumed with a Buy at H.C. Wainwright
- Akero Therapeutics’ Efruxifermin Study: A Potential Game-Changer for NASH Treatment